Ensifentrine, a Novel Dual Phosphodiesterase (PDE) 3 and 4 Inhibitor, Significantly Improves COPD Symptoms and Quality of Life in the Phase 3 Enhance-1 Trial

被引：0
|
作者：
Sciurba, F. C. [1 ]
Rheault, T. [2 ]
Bengtsson, T. [3 ]
Rickard, K. [2 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[2] Verona Pharma Plc, Raleigh, NC USA
[3] Stat Mind AB, Lund, Sweden
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5007
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials)
    Anzueto, Antonio
    Barjaktarevic, Igor Z.
    Siler, Thomas M.
    Rheault, Tara
    Bengtsson, Thomas
    Rickard, Kathleen
    Sciurba, Frank
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (04) : 406 - 416
  • [32] Safety of Dual PDE3/4 Inhibitor Ensifentrine Added to Tiotropium: Gastrointestinal and Cardiovascular Adverse Events from a Four-Week Randomized, Controlled Trial
    Rickard, K.
    Bengtsson, T.
    Rheault, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [33] VIBEGRON STATISTICALLY SIGNIFICANTLY IMPROVES MEASURES OF QUALITY OF LIFE IN PATIENTS WITH OVERACTIVE BLADDER - DATA FROM THE INTERNATIONAL PHASE 3 TRIAL (EMPOWUR)
    Varano, S.
    Staskin, D.
    Frankel, J.
    Shortino, D.
    Jankowich, R.
    Mudd, P. N.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2019, 30 : S22 - S23
  • [34] Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results of a Phase 3, Randomized, Controlled Trial (PALACE 1)
    Adebajo, A. O.
    Kavanaugh, A.
    Mease, P. J.
    Gomez-Reino, J. J.
    Wollenhaupt, J.
    Hu, C.
    Stevens, R.
    CLINICAL RHEUMATOLOGY, 2013, 32 : S123 - S123
  • [35] Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis: results of a phase 3, randomized, controlled trial (palace 1)
    Adebajo, A. O.
    Kavanaugh, A.
    Mease, P. J.
    Gomez-Reino, J. J.
    Wollenhaupt, J.
    Hu, C.
    Stevens, R.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 53 - 54
  • [36] Dupilumab improves quality of life in non-exacerbators with moderate-to-severe COPD and type 2 inflammation: phase 3 BOREAS trial
    Rabe, Klaus F.
    Vogelmeier, Claus F.
    Bhatt, Surya P.
    Hanania, Nicola A.
    Bafadhel, Mona
    Christenson, Stephanie
    Papi, Alberto
    Singh, Dave
    Laws, Elizabeth
    Maloney, Jennifer
    Lu, Xin
    Bauer, Deborah
    Bansal, Ashish
    Robinson, Lacey B.
    Abdulai, Raolat M.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [37] APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS: PHARMACODYNAMIC RESULTS OF A PHASE 3, RANDOMIZED, CONTROLLED TRIAL (PALACE 1)
    Schafer, P.
    Chen, P.
    Fang, L.
    Wang, A.
    Chopra, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 739 - 740
  • [38] Anti-inflammatory effect of a novel inhaled dual PDE3/4 inhibitor RPL554 in man, a unique "first-in-class" drug for the treatment of COPD & asthma
    Singh, Dave
    Reid, Fred
    Franciosi, Lui
    Walker, Michael
    Page, Clive
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [39] A Phase I, Randomised, Double Blind, Placebo Controlled, Study To Assess The Safety, Tolerability And Pharmacokinetics Of Single Inhaled Doses Of The Dual Phosphodiesterase 3/4 (pde3/4) Inhibitor Rpl554 Administered By Nebuliser To Healthy Male Subjects
    Singh, D.
    Abbott-Banner, K. H.
    Reid, F.
    Newman, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [40] Determination of a novel phosphodiesterase4 inhibitor, 3-[1-(3cyclopropylmethoxy-4-difluoromethoxybenzyl)-1H-pyrazol-3-yl]benzoic acid (PDE-423) in rat plasma using liquid chromatography-tandem mass spectrometry
    Cho, Woon-Ki
    Seo, Hyewon
    Choi, Sung Heum
    Kwak, Hyun Jeong
    Cheon, Hyae Gyeong
    Jeon, Dong Ju
    Kim, Sang Kyum
    Bae, Myung Ae
    Song, Jin Sook
    BIOMEDICAL CHROMATOGRAPHY, 2015, 29 (03) : 321 - 324
12345